Literature DB >> 21821767

Lytic myophage Abp53 encodes several proteins similar to those encoded by host Acinetobacter baumannii and phage phiKO2.

Chia-Ni Lee1, Tsai-Tien Tseng, Juey-Wen Lin, Yung-Chieh Fu, Shu-Fen Weng, Yi-Hsiung Tseng.   

Abstract

Acinetobacter baumannii is an important Gram-negative opportunistic pathogen causing nosocomial infections. The emergence of multiple-drug-resistant A. baumannii isolates has increased in recent years. Directed toward phage therapy, a lytic phage of A. baumannii, designated Abp53, was isolated from a sputum sample in this study. Abp53 has an isometric head and a contractile tail with tail fibers (belonging to Myoviridae), a latent period of about 10 min, and a burst size of approximately 150 PFU per infected cell. Abp53 could completely lyse 27% of the A. baumannii isolates tested, which were all multiple drug resistant, but not other bacteria. Mg(2+) enhanced the adsorption and productivity of, and host lysis by, Abp53. Twenty Abp53 virion proteins were visualized in SDS-polyacrylamide gel electrophoresis, with a 47-kDa protein being the predicted major capsid protein. Abp53 has a double-stranded DNA genome of 95 kb. Sequence analyses of a 10-kb region revealed 8 open reading frames. Five of the encoded proteins, including 3 tail components and 2 hypothetical proteins, were similar to proteins encoded by A. baumannii strain ACICU. ORF1176 (one of the tail components, 1,176 amino acids [aa]), which is also similar to tail protein gp21 of Klebsiella phage phiKO2, contained repeated domains similar to those within the ACICU_02717 protein of A. baumannii ACICU and gp21. These findings suggest a common ancestry and horizontal gene transfer during evolution. As phages can expand the host range by domain duplication in tail fiber proteins, repeated domains in ORF1176 might have a similar significance in Abp53.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21821767      PMCID: PMC3187083          DOI: 10.1128/AEM.05116-11

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  55 in total

1.  The pKO2 linear plasmid prophage of Klebsiella oxytoca.

Authors:  Sherwood R Casjens; Eddie B Gilcrease; Wai Mun Huang; Kim L Bunny; Marisa L Pedulla; Michael E Ford; Jennifer M Houtz; Graham F Hatfull; Roger W Hendrix
Journal:  J Bacteriol       Date:  2004-03       Impact factor: 3.490

2.  Community-acquired bacteremic Acinetobacter pneumonia in tropical Australia is caused by diverse strains of Acinetobacter baumannii, with carriage in the throat in at-risk groups.

Authors:  Nicholas M Anstey; Bart J Currie; Marilyn Hassell; Didier Palmer; Brian Dwyer; Harald Seifert
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

3.  Species, biotype, and bacteriophage type determinations compared with cell envelope protein profiles for typing Acinetobacter strains.

Authors:  P J Bouvet; S Jeanjean; J F Vieu; L Dijkshoorn
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

4.  A novel lysozyme from Xanthomonas oryzae phage varphiXo411 active against Xanthomonas and Stenotrophomonas.

Authors:  Chia-Ni Lee; Juey-Wen Lin; Te-Yuan Chow; Yi-Hsiung Tseng; Shu-Fen Weng
Journal:  Protein Expr Purif       Date:  2006-06-27       Impact factor: 1.650

5.  Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology, and antimicrobial susceptibility.

Authors:  H Wisplinghoff; M B Edmond; M A Pfaller; R N Jones; R P Wenzel; H Seifert
Journal:  Clin Infect Dis       Date:  2000-10-04       Impact factor: 9.079

6.  Interaction of bacteriophage lambda with its cell surface receptor: an in vitro study of binding of the viral tail protein gpJ to LamB (Maltoporin).

Authors:  Emir Berkane; Frank Orlik; Johannes F Stegmeier; Alain Charbit; Mathias Winterhalter; Roland Benz
Journal:  Biochemistry       Date:  2006-02-28       Impact factor: 3.162

7.  Comparison of four different methods for epidemiologic typing of Acinetobacter baumannii.

Authors:  H Seifert; A Schulze; R Baginski; G Pulverer
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

8.  Factors influencing the adsorption of bacteriophage 2 to cells of Pseudomonas aeruginosa.

Authors:  J F Reese; G Dimitracopoulos; P F Bartell
Journal:  J Virol       Date:  1974-01       Impact factor: 5.103

9.  A study of the relationships between antibiotic resistance phenotypes, phage-typing and biotyping of 117 clinical isolates of Acinetobacter spp.

Authors:  M L Joly-Guillou; E Bergogne-Berezin; J F Vieu
Journal:  J Hosp Infect       Date:  1990-07       Impact factor: 3.926

10.  Acinetobacter spp. in gunshot injuries.

Authors:  James W T Elston; Ciaran L Bannan; Desmond T Chih; Craig S Boutlis
Journal:  Emerg Infect Dis       Date:  2008-01       Impact factor: 6.883

View more
  12 in total

1.  Characterization and Detection of Endolysin Gene from Three Acinetobacter baumannii Bacteriophages Isolated from Sewage Water.

Authors:  Thawatchai Kitti; Rapee Thummeepak; Aunchalee Thanwisai; Kamala Boonyodying; Duangkamol Kunthalert; Pannika Ritvirool; Sutthirat Sitthisak
Journal:  Indian J Microbiol       Date:  2014-05-21       Impact factor: 2.461

2.  In Vivo Application of Bacteriophage as a Potential Therapeutic Agent To Control OXA-66-Like Carbapenemase-Producing Acinetobacter baumannii Strains Belonging to Sequence Type 357.

Authors:  Jongsoo Jeon; Choong-Min Ryu; Jun-Young Lee; Jong-Hwan Park; Dongeun Yong; Kyungwon Lee
Journal:  Appl Environ Microbiol       Date:  2016-06-30       Impact factor: 4.792

3.  Complete genome sequence of the podoviral bacteriophage YMC/09/02/B1251 ABA BP, which causes the lysis of an OXA-23-producing carbapenem-resistant Acinetobacter baumannii isolate from a septic patient.

Authors:  Jongsoo Jeon; Jae-won Kim; Dongeun Yong; Kyungwon Lee; Yunsop Chong
Journal:  J Virol       Date:  2012-11       Impact factor: 5.103

4.  Characterization of newly isolated lytic bacteriophages active against Acinetobacter baumannii.

Authors:  Maia Merabishvili; Dieter Vandenheuvel; Andrew M Kropinski; Jan Mast; Daniel De Vos; Gilbert Verbeken; Jean-Paul Noben; Rob Lavigne; Mario Vaneechoutte; Jean-Paul Pirnay
Journal:  PLoS One       Date:  2014-08-11       Impact factor: 3.240

5.  Comparative Analysis of 37 Acinetobacter Bacteriophages.

Authors:  Dann Turner; Hans-Wolfgang Ackermann; Andrew M Kropinski; Rob Lavigne; J Mark Sutton; Darren M Reynolds
Journal:  Viruses       Date:  2017-12-24       Impact factor: 5.048

6.  Atomic force microscopy analysis of the Acinetobacter baumannii bacteriophage AP22 lytic cycle.

Authors:  Evgeniy V Dubrovin; Anastasia V Popova; Sergey V Kraevskiy; Sergei G Ignatov; Tatyana E Ignatyuk; Igor V Yaminsky; Nikolay V Volozhantsev
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

7.  Characterization, sequencing and comparative genomic analysis of vB_AbaM-IME-AB2, a novel lytic bacteriophage that infects multidrug-resistant Acinetobacter baumannii clinical isolates.

Authors:  Fan Peng; Zhiqiang Mi; Yong Huang; Xin Yuan; Wenkai Niu; Yahui Wang; Yuhui Hua; Huahao Fan; Changqing Bai; Yigang Tong
Journal:  BMC Microbiol       Date:  2014-07-05       Impact factor: 3.605

8.  Two New Lytic Bacteriophages of the Myoviridae Family Against Carbapenem-Resistant Acinetobacter baumannii.

Authors:  Weilong Zhou; Yu Feng; Zhiyong Zong
Journal:  Front Microbiol       Date:  2018-04-30       Impact factor: 5.640

9.  Isolation of bacteriophages against multidrug resistant Acinetobacter baumannii.

Authors:  Hasan Ghajavand; Bahram Nasr Esfahani; Asghar Havaei; Hossein Fazeli; Reyhaneh Jafari; Sharareh Moghim
Journal:  Res Pharm Sci       Date:  2017-10

10.  Isolation and Characterization of a Novel Myophage Abp9 Against Pandrug Resistant Acinetobacater baumannii.

Authors:  Lingli Jiang; Jingjie Tan; Yi Hao; Qi Wang; Xiaorui Yan; Dali Wang; Li Tuo; Zairong Wei; Guangtao Huang
Journal:  Front Microbiol       Date:  2020-09-08       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.